Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Return on Equity (2016 - 2025)

Historic Return on Equity for Marimed (MRMD) over the last 14 years, with Q3 2025 value amounting to 0.31%.

  • Marimed's Return on Equity fell 1100.0% to 0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 0.19% for FY2024, which is 600.0% up from last year.
  • Latest data reveals that Marimed reported Return on Equity of 0.31% as of Q3 2025, which was down 1100.0% from 0.27% recorded in Q2 2025.
  • In the past 5 years, Marimed's Return on Equity registered a high of 1.01% during Q2 2021, and its lowest value of 0.31% during Q3 2025.
  • Over the past 5 years, Marimed's median Return on Equity value was 0.04% (recorded in 2022), while the average stood at 0.09%.
  • As far as peak fluctuations go, Marimed's Return on Equity tumbled by -844900bps in 2021, and later surged by 400bps in 2022.
  • Marimed's Return on Equity (Quarter) stood at 0.21% in 2021, then rose by 17bps to 0.25% in 2022, then crashed by -186bps to 0.21% in 2023, then grew by 12bps to 0.19% in 2024, then tumbled by -66bps to 0.31% in 2025.
  • Its last three reported values are 0.31% in Q3 2025, 0.27% for Q2 2025, and 0.27% during Q1 2025.